Matthew Mossanen MD, MPH
Assistant Professor of Surgery, Harvard Medical School, Brigham and Women's Hospital, Division of Urology, Boston, MassachusettsDr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and he received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.
His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer
Recent Contributions to PracticeUpdate:
- Upper Tract Urothelial Cell Carcinoma: Part 1
- Upper Tract Urothelial Cell Carcinoma: Part 2
- Genitourinary Tumor Board: Bladder Cancer
- Renal Masses in a Functionally Solitary Kidney: Adjuvant Therapy
- Health-Related QoL of Patients With Bladder Cancer Undergoing Robot vs Open Radical Cystectomy
- Outcomes and Recurrence Patterns of Sarcomatoid Urothelial Carcinoma
- Practical Issues With Use of Edrafitinib in Urothelial Carcinoma
- Analysis of Recurrence After Neoadjuvant Bladder Cancer Treatment: Practical Implications
- ASCO: Outcomes of Patients With Metastatic Urothelial Carcinoma Following Discontinuation of Enfortumab-Vedotin
- ASCO: Adjuvant Chemotherapy Plus Novel Therapies for Muscle-Invasive Bladder Cancer